Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3793_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
09.09.2026
Размер:
18 Мб
Скачать
304 PART IV Noncoronary Diseases: Diagnosis and Management
https://t.me/medicina_free
manifestation, cardiac tamponade. Factors that determine the degree of hemodynamic compromise include the size of the effusion; its rate of accumulation; and whether the pericardium
A
B
Fig. 29.2 Echocardiogram showing a large circumferential
pericardial effusion. Anterior (A) and posterior (B) aspects of the effusions are shown. (From Shabetai R. Pericardial disease. In: Brown DL, ed. Cardiac Intensive Care. Philadelphia: Saunders; 1988:469–475.)
compression of adjacent intrathoracic structures results in hoarse­ness, hiccough, and nausea.15 Therefore clinicians must maintain a high index of suspicion for pericardial effusion, particularly in the intensive care setting, where it is common for many patients to have undergone percutaneous cardiac procedures that can be complicated by perforation of coronary arteries, the coronary sinus, or the cardiac chambers.
On the ECG, pericardial fluid appears as an echolucent space between the pericardium and the epicardium (Fig. 29.2). Pericardial effusions are classified according to their onset, size, distribution, hemodynamic impact, and composition.15 The detec­tion of a pericardial effusion often has important implications for diagnosis (e.g., acute pericarditis after MI), prognosis (e.g., patients with cancer), or both (e.g., acute aortic dissection). Rapidly accumulating blood in the pericardial space may be seen in CICU patients with blunt trauma, ascending aortic dis­section, cardiac rupture that may complicate MI, or after invasive cardiac procedures. After cardiac surgery, pericardial effusions are common but are typically not large and usually resolve without medication by 1 month; late (>1 week) tamponade is unusual (1 to 2%) and the effusions appear not to be responsive to NSAIDs or colchicine.
Pericardial effusion should be suspected in patients with any systemic disorder known to involve the pericardium, elevated JVP, chest pain consistent with pericarditis or aortic dissection, unexplained cardiomegaly (especially with a flask-shaped cardiac silhouette) without pulmonary congestion on chest radiograph, persistent fever with or without an obvious source of infection, the presence of an isolated left pleural effusion and a fever, or hemodynamic deterioration in a patient with another disease process (or after an invasive cardiac procedure) that can involve the pericardium.
15
CARDIAC (PERICARDIAL) TAMPONADE
The potential hemodynamic impact of an effusion ranges from none to mild compromise to the most extreme clinical
is inflamed, scarred, or adherent. Localized pericardial adhesions or organization of the pericardial fluid can result in localized tamponade, which is most common after cardiac surgery and may be difficult to recognize. Diffuse pericardial inflammation and/or scarring with effusion can result in effusive-constrictive pericarditis, which has features of both cardiac tamponade and pericardial constriction.
6
If fluid accumulation is gradual, pericardial pressure remains low because the pericardium can increase its compliance by undergoing stretch. However, with continued accumulation of fluid, the pericardial reserve volume (the difference between unstressed pericardial volume and cardiac volume that accom­modates physiologic changes in ventricular filling) is exceeded and the intrapericardial pressure eventually increases; once this becomes high enough to impede cardiac filling, cardiac output
1,2
falls.
Cardiac tamponade is a hemodynamic condition characterized by equal elevation of atrial (pulmonary capillary wedge and right atrial) and pericardial pressures, an exaggerated (>10 mm Hg) inspiratory decrease in aortic systolic pressure (pulsus paradoxus) and arterial hypotension (Fig. 29.3). The pathophysiol­ogy of cardiac tamponade and pulsus paradoxus readily explains findings on clinical examination, Doppler echocardiography, and at cardiac catheterization. The primary abnormality is compres­sion of the cardiac chambers owing to increased pericardial pressure that is exerted throughout the cardiac cycle. While the pericardium has some degree of elasticity (part of the pericardial reserve volume), once the elastic limit is reached, the heart must compete with the intrapericardial fluid for a fixed intrapericardial volume.2 As the total pericardial volume reaches the stiff portion of its pressure–volume relation, tamponade rapidly ensues. As cardiac tamponade progresses, the cardiac chambers become smaller, transmural chamber pressures (i.e., preload) decrease, and diastolic chamber compliance and ventricular filling decrease owing to enhanced ventricular interdependence, which lead to the characteristic elevation and equalization of diastolic filling pressures and decreases in stroke volume and blood pressure.
It is important to realize that the clinical presentation and diagnostic findings associated with tamponade physiology are not all-or-none phenomena. Rather, the clinical presentation— echocardiographic and catheterization features present in tamponade—lie on a spectrum of severity that is dependent as much on the acuity of presentation and etiology as the patient’s underlying comorbidities (e.g., ventricular dysfunction, volume status, valvular disease) and the ability to sustain a compensatory physiologic response.
Patients with acute tamponade may present with chest pain, tachypnea, or altered consciousness owing to decreased cardiac output. On examination, the classic triad of hypotension, elevated JVP, and diminished heart sounds (one of Beck’s triads) is present in only a minority of patients. patients with known tamponade suggested that five features were present in a majority of patients: dyspnea (87% to 89% sensitive), tachycardia (77% sensitive), pulsus paradoxus (82% sensitive),
16
A recent systematic review of
CHAPTER 29 Acute Pericardial Disease 305
100
0
0
https://t.me/medicina_free
90
70
50 20
20
10
Fig. 29.3 Hyperacute cardiac tamponade caused by penetration of a saphenous vein graft during
angioplasty of the graft. The radial arterial tracing shows tachycardia and extreme pulsus paradoxus. The right atrial and pericardial pressures are equilibrated at a very high level. The volume of blood in the pericardium was small.
Rt. atrium
Peri
Radial artery
10
elevated JVP (76% sensitive), and cardiomegaly on chest radio­graph (89% sensitive), while another review suggests that the presence of pulsus paradoxus greater than 10 mm Hg in patients with effusion increases the likelihood of tamponade (likelihood ratio, 3.3).
17
Echocardiography is the preferred diagnostic modality for identifying the hallmarks of tamponade physiology, that is, cardiac chamber collapses (most often right atrial and right ventricular), exaggerated respiratory variation of cardiac chamber dimensions, and transvalvular flow velocities and inferior vena cava (IVC) dilation with reduced respiratory change in dimension (vena caval plethora; see Videos 29.1 to 29.4). Cardiac chamber collapse occurs when the intrapericardial pressure exceeds the intracardiac pressure in a given chamber; the right ventricular (RV) free wall buckles or invaginates in early diastole when RV pressure is at a minimum. This is often best visualized in the subcostal view with an M-mode cursor through the affected chamber wall to determine timing within the cardiac cycle.
2
Early-diastolic RV collapse is highly specific for tamponade, although other condi­tions can reproduce this finding in the absence of a hemodynami­cally significant effusion.18 At end-diastole when right atrial pressure is at its nadir, pericardial fluid pressure exceeds right atrial pressure, resulting in right atrial collapse, often best appreci­ated in four-chamber imaging (Fig. 29.4). If persistent for longer than one-third of diastole, the sensitivity, specificity, and positive predictive values approach 100% in patients with tamponade.19 The degree of invagination has no predictive value for the presence of tamponade. It is important to note that the absence of any chamber collapse has a nearly 90% negative predictive value for clinically significant tamponade.20 Collapse of the left atrium and the left ventricle are less common; the latter is usually in the presence of right ventricular pressure and volume overload or when tamponade is regional (e.g., after cardiac surgery).
Inspiration
L
Fig. 29.4 Echocardiogram showing severe right atrial compres-
sion (arrow) in a patient whose pericardial effusion had caused cardiac tamponade. L, Left ventricle. (From Shabetai R. Pericardial disease. In: Brown DL, ed. Cardiac Intensive Care. Philadelphia: Saunders; 1988:469–475.)
In normal individuals, there is minimal variation in flow velocity during normal respiration. In tamponade, exaggerated respiratory variation in transvalvular velocities results from enhanced ventricular interdependence and suggests the presence of pulsus paradoxus. With inspiration, tricuspid flow velocity increases markedly, with a concomitant decrease in mitral flow velocity. By recent consensus, the percentage of respiratory variation for mitral and tricuspid inflow is calculated as: 100 × (expiration – inspiration)/expiration.6 In tamponade, tricuspid flow variance usually exceeds 60%, while mitral flow exceeds
306 PART IV Noncoronary Diseases: Diagnosis and Management
https://t.me/medicina_free
30%. It is important to note that transvalvular flow velocity should not be the sole criterion used for the diagnosis of tam­ponade.6 IVC plethora is present in many patients with tamponade. In one study, up to 92% of patients with an effusion requiring drainage were found to have dilation and less than 50% inspiratory decrease in the diameter of the IVC during inspiration, findings suggestive of elevated central venous pressure.21 While this finding is highly sensitive, it lacks specificity, as many other conditions are associated with increased right atrial pressure and have the same echocardiographic finding.
LOW PRESSURE TAMPONADE
Patients who are severely hypovolemic because of traumatic hemorrhage, hemodialysis and ultrafiltration, excessive GI losses, or excessive diuresis may have low pressure tamponade, in which the intracardiac and pericardial diastolic pressures are only 6 to 12 mm Hg (Fig. 29.5).22 In 143 patients with cardiac tamponade (equal pericardial and right atrial pressures before pericardio­centesis), 29 had an initial pericardial pressure less than 7 mm Hg; the spectrum of etiologies and the frequency and severity of echocardiographic findings were similar to patients with classic cardiac tamponade.22 However, clinical findings associated with classic cardiac tamponade—including increased heart rate, elevated JVP, and pulsus paradoxus—were significantly less common. As such, clinicians should maintain a high index of suspicion for tamponade in patients with confounding conditions that may affect the hemodynamic response to elevated intra­pericardial pressure. Treatment consists of intravenous fluid replacement and pericardiocentesis.
Causes of Tamponade in the CICU
While the majority of cases of tamponade in the CICU are likely to be related to MI and coronary/cardiac interventions, cases of
EXP. INSP.
Ao
RV
Fig. 29.5 Low-pressure cardiac tamponade. The right ventricular
pressure was only 10 mm Hg, but otherwise the characteristic hemodynamic abnormalities of severe tamponade were present, including pulsus paradoxus, which was out of phase between the right ventricle (RV) and the aorta (Ao), and absence of an early diastolic dip. EXP, Expiration; INSP, inspiration. (From Shabetai R. Cardiac tamponade. In: Shabetai R, ed. The Pericar- dium. Norwell, MA: Kluwer Academic Press; 2003:122–166.)
100
90 80 70 60 50 40 30 20
10
–0
cardiac tamponade owing to a variety of causes may be admitted to the CICU for monitoring and treatment. After MI, cardiac tamponade may complicate both early post-MI pericarditis, Dressler syndrome, and cardiac rupture. While the latter is often immediately fatal, the rate of intrapericardial hemorrhage may be slow enough or contained to allow detection (usually by echocardiography with contrast) and surgical repair of the rupture and any resultant pseudoaneurysm.
Treatment of Cardiac Tamponade
The 2015 ESC Guidelines treatment recommendations include targeting the therapy of pericardial effusion to the specific etiology whenever possible, the use of ASA/NSAID/colchicine when effusion is associated with systemic inflammation, pericardio­centesis or cardiac surgery for cardiac tamponade or symptomatic moderate to large effusions that are not responsive to medical therapy, and for suspicion of unknown bacterial or neoplastic pericarditis (all IC recommendations).
The choice between pericardiocentesis (see Chapter 44 and open surgical drainage is based on local preference and experience, the etiology of the effusion, hemodynamic status of the patient, and characteristics of the pericardial fluid/contents. Generally, for a majority of free-flowing or uncomplicated effusions, echo­guided percutaneous drainage is preferred in the hands of a skilled operator. Conversely, the presence of loculated or organized fluid, hemopericardium, a traumatic etiology of the effusion, or concern for aortic dissection may be best served with surgical evacuation of the pericardium.
15
Pericardiocentesis can be performed under fluoroscopic or echocardiographic guidance. The latter allows the operator to select the shortest route to the effusion and the puncture site with the largest collection of fluid. In the largest published series, the para-apical location was utilized in two-thirds, while the subxiphoid location was ideal in only 15%.23 An indwelling pericardial catheter with intermittent or continuous suction is left in the pericardial space until the rate of fluid return is negligible (<25 mL/d). Following drainage, whether percutaneous or surgical, patients should remain on telemetry for at least 24 hours, with a two-dimensional Doppler echocardiogram com­pleted prior to hospital discharge to evaluate for fluid reaccumula­tion. Early follow-up echocardiography 1 to 2 weeks after discharge to evaluate for recurrence or early constriction should be con­sidered in the appropriate setting.
Surgical pericardiectomy with drainage, though less commonly performed than pericardiocentesis, is often preferred when the pericardial effusion has reaccumulated, is loculated, biopsy of the pericardium is desired, or the patient has a coagulopathy. For both chronic and recurrent effusions, the 2015 ESC Guidelines recommend surgical pericardiectomy only in patients with symptomatic effusions in whom medical therapy and repeated pericardiocenteses were not successful.
Patients who are diagnosed with a large pericardial effusion with minimal or no evidence of hemodynamic compromise may be treated conservatively with careful hemodynamic monitoring, serial echocardiographic studies, avoidance of diuretics and vasodilators (a IIIC recommendation), and therapy aimed at the underlying cause of the pericardial effusion. Effusions that
15
15
15
CHAPTER 29 Acute Pericardial Disease 307
https://t.me/medicina_free
progressively enlarge, lead to worsening symptoms suggesting cardiac tamponade, or that are otherwise refractory to a conserva­tive approach should be treated with pericardial fluid drainage. There is no role for medical therapy of cardiac tamponade, but fluid resuscitation may be helpful while preparing for pericardial drainage. Mechanical ventilation should be avoided whenever possible.
CONSTRICTIVE PERICARDITIS
Constrictive pericarditis can occur following virtually any cause of pericarditis but most commonly occurs after idiopathic/viral, postcardiac surgery, and following radiation therapy. It may present transiently (i.e., either spontaneous resolution or response to medical therapy), subacutely, or chronically. Constrictive pericarditis is seldom an indication for admission to the CICU, but intensivists might manage patients with transient or subacute presentations that may clinically resemble cardiac tamponade. Patients with chronic constriction often present with exertional dyspnea, lower extremity edema, fatigue, or abdominal distention and, in rare instances, congestive hepatopathy. Distinguishing constrictive pericarditis from cardiac tamponade, acute decom­pensated heart failure, and disorders such as restrictive cardio­myopathy and chronic liver disease is essential, as treatments are markedly different. The critical pathophysiologic features of constrictive pericarditis—which are responsible for the physical examination, hemodynamic, and imaging findings—are enhanced ventricular interaction (interdependence) and dissociation of intracardiac and intrathoracic pressures.
The physical exam in constriction is notable for elevated jugular venous pressure (reported in as many as 93% of patients with surgically confirmed constrictive pericarditis), hepatomegaly, splenomegaly, ascites, and edema. The jugular venous waveform demonstrates prominent x and y descents. The Kussmaul sign (failure of the JVP to decrease with inspiration) is an examination finding relatively specific to constriction but does not distinguish constrictive pericarditis from severe tricuspid valve disease or right-sided heart failure. In contrast, pulsus paradoxus is rare and, if present, should raise suspicion for effusive-constrictive disease (pericardial constriction with a concomitant effusion). A pericardial knock, an accentuated heart sound that occurs slightly earlier than an S approximately 50% of cases.
, is distinctive but reported in only
3
Patients with suspected constrictive pericarditis should undergo initial evaluation with ECG, chest radiograph, and echocardiog­raphy. Unlike patients with cardiomyopathy, B-type natriuretic peptide (BNP) and N-terminal pro-BNP levels are usually only mildly elevated in constriction. Two-dimensional Doppler echocardiography is critical in the diagnosis of constriction and in differentiating constriction from tamponade, effusive­constrictive disease, and restrictive cardiomyopathy.
24
The most specific echocardiographic sign of constriction is a septal bounce with abrupt transient rightward movement of the interventricular septum. Doppler echocardiography demonstrates elevated early diastolic tissue Doppler velocities (é) with the septal e often greater than the lateral é tissue velocity (annulus paradoxus) and an expiratory increase in early mitral inflow velocity greater than 25% and an expiratory decrease of tricuspid inflow greater than 40%.6 Computed tomography, magnetic resonance imaging, and cardiac catheterization are useful to confirm the diagnosis, particularly in patients with nondiag­nostic echocardiographic findings, and to assist in perioperative management. Delayed enhancement cardiac magnetic resonance is valuable to assess the extent of pericardial inflammation and the response to antiinflammatory medications in patients with increased inflammatory biomarkers or a short duration (<3 months) of constrictive symptoms.
6
For patients with newly diagnosed constrictive pericarditis who are hemodynamically stable and do not have evidence of chronic constriction, a trial of conservative management rather than pericardiectomy is warranted. Pericardiectomy is the only definitive treatment option for patients with chronic symptomatic constrictive pericarditis.
CONCLUSION
While the spectrum of pericardial disease varies from benign to life threatening, failure to recognize pericardial disease, particularly in the setting of shock, can have devastating consequences. Often, a simple ECG and two-dimensional Doppler echocardiography, in the hands of a skilled clinician, will provide both a diagnosis and assist in facilitating timely management of patients with hemodynamic embarrassment due to pericardial disease.
The full reference list for this chapter is available at
ExpertConsult.com.
CHAPTER 29 Acute Pericardial Disease 307.e1
https://t.me/medicina_free
REFERENCES
1. Hoit BD. Pathophysiology of the pericardium. Prog Cardiovasc Dis. 2016. Dec 1. pii: S0033-0620(16)30133-5.
2. Spodick DH. Acute cardiac tamponade. N Engl J Med. 2003;349:684–690.
3. Kyto V, Sipila J, Rautava P. Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis. Circulation. 2014;130:1601–1606.
4. Throughton RW, Asher CR, Klein AL. Pericarditis. Lancet. 2004;363:717–727.
5. Imazio M, Gaita F, LeWinter M. Evaluation and treatment of pericarditis: a systematic review. JAMA. 2015;314(14):1498–1506.
6. Klein AL, Abbara S, Agler DA, et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2013;26:965–1012.
7. Imazio M, Brucato A, Maestroni S, et al. Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis. Circulation. 2011;123:1092–1097.
8. Imazio M, Demichelis B, Cecchi E, et al. Cardiac troponin I in acute pericarditis. J Am Coll Cardiol. 2003;42:2144–2148.
9. Imazio M, Demichelis B, Parrini I, et al. Day-hospital treatment of acute pericarditis: a management program for outpatient therapy. J Am Coll Cardiol. 2004;43:1042–1046.
10. Imazio M, Bobbio M, Cecchi E, et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation. 2005;112:2012–2016.
11. Imazio M, Brucato A, Forno D, et al. Efficacy and safety of colchicine for pericarditis prevention. Systematic review and meta- analysis. Heart. 2012;98:1078.
12. Alabed S, Cabello JB, Irving GJ, et al. Colchicine for pericarditis. Cochrane Database Syst Rev. 2014;(8).
13. Imazio M, Brucato A, Belli R, et al. Colchicine for the prevention of pericarditis: what we know and what we do not known in
2014- systematic review and meta-analysis. J Cardiovasc Med (Hagerstown). 2014;15:840–846.
14. Schwier N, Tran N. Non-steroidal anti-inflammatory drugs and aspirin therapy for the treatment of acute and recurrent idiopathic pericarditis. Pharmaceuticals (Basel). 2016;9:pii: E17.
15. Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial disease. Eur Heart J. 2015;36:2921–2964.
16. Seferovic SM, Ristic AD, Imazio M, et al. Management strategies in pericardial emergencies. Herz. 2006;31(9):891–900.
17. Roy C, Minor MA, Brookhart MA, et al. Does this patient with a pericardial effusion have cardiac tamponade? JAMA. 2007;297:1810–1818.
18. Armstrong WF, Schilt BF, Helper DJ, et al. Diastolic collapse of the right ventricle with cardiac tamponade: an echocardiographic study. Circulation. 1982;65:1491–1496.
19. Gillam LD, Guyer DE, Gibson TC, et al. Hydrodynamic compression of the right atrium: a new echocardiographic sign of cardiac tamponade. Circulation. 1983;68:294–301.
20. Merce J, Sagrista-Sauleda J, Permanyer-Miralda G, et al. Correlation between clinical and Doppler echocardiographic findings in patients with moderate and large pericardial effusion: implications for the diagnosis of cardiac tamponade. Am Heart J. 1999;138:759–764.
21. Himelman RB, Kircher B, Rockey DL, Schiller NB. Inferior vena cava plethora with blunted respiratory response: a sensitive echocardiographic sign of cardiac tamponade. J Am Coll Cardiol. 1988;12:1470–1477.
22. Sagrista-Sauleda J, Angel J, Sambola A, et al. Low-pressure cardiac tamponade: clinical and hemodynamic profile. Circulation. 2006;114:945–952.
23. Tsang TSM, Enriquez-Sarano M, Freeman WK, et al. Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: clinical profile, practice patterns, and outcomes spanning 21 years. Mayo Clin Proc. 2002;77:429–436.
24. Garcia MJ. Constrictive pericarditis versus restrictive cardiomyopathy. J Am Coll Cardiol. 2016;67:2061–2076.
30
22
60
.)
https://t.me/medicina_free
Acute Respiratory Failure
Holly Keyt, Jay I. Peters
OUTLINE
Physiology of Gas Exchange, 308 Pathophysiology of Acute Respiratory Failure, 309 Clinical Assessment, 310
Differential Diagnosis, 311
Management, 314
Mechanical Ventilation, 315 Extracorporeal Membrane Oxygenation, 317
Conclusion, 317
Respiratory failure is defined as the inability to maintain either
the normal delivery of oxygen to tissues or the normal removal of carbon dioxide from the tissues. From a physiologic perspective, respiratory failure can be caused by diffuse pulmonary dysfunction (ventilation/perfusion [V/Q] mismatch or pulmonary shunt), neurologic dysfunction (depression of the respiratory drive), cardiac dysfunction (low cardiac output or pulmonary edema), or a lack of hemoglobin to transport gases. Clinically, this is seen as arterial hypoxemia leading to tissue hypoxia and/or arterial hypercapnia. Acute respiratory failure (ARF) may evolve over a period of minutes to hours to days depending on the clinical situation. ARF, therefore, is a generic term that encompasses a heterogeneous spectrum of diseases that eventually end with the same pathophysiologic outcomes: arterial hypoxemia (usually with partial pressure of O2 [PaO2] of <60 mm Hg) or hypercapnia (partial pressure of CO2 [PaCO2] of >45 to 50 mm Hg).
PHYSIOLOGY OF GAS EXCHANGE
In the lung, gas exchange occurs at the capillary-alveolar interface. Microscopic examination of septal capillaries reveals that they are significantly thinner on the side that bulges into the air space. This conformation enhances the diffusion of oxygen from the air space into the blood and the elimination of carbon dioxide from the blood into the air space. Equilibration of partial pressures of gases between the two compartments occurs rapidly. Oxygen in the blood is carried by hemoglobin. Only a small percentage is transported as dissolved gas. The following equation describes the arterial oxygen content (CaO
CO HgbSaO PaO
where CaO2 is the oxygen content of arterial blood in milliliters of O2 per deciliter of blood; Hgb is the hemoglobin concentration in grams per deciliter of blood; SaO2 (oxygen saturation) is the fraction of hemoglobin sites bound by oxygen; and PaO2 is the arterial partial pressure of oxygen.
a2
13
):
2
003=××+ ×(. )(
Because the amount of dissolved oxygen is small in comparison to the amount transported by hemoglobin, in most clinical situ­ations, CaO and the oxygen saturation of the arterial blood, not on PaO2. Even in severe anemia, the contribution of dissolved oxygen in the overall CaO2 is negligible despite very high PaO2. This principle is important clinically in patients with ARF for whom increasing CaO2 can be accomplished by increasing hemoglobin concentra­tion and SaO2, but not necessarily by increasing PaO2. This follows from the sigmoid shape of the oxygen-hemoglobin dissociation curve, in which significantly higher PaO2 is needed to increase the SaO2 beyond 90% as the curve plateaus.
Carbon dioxide is transported in the blood mostly in the form of carbonic acid. Only approximately 5% is transported by binding with hemoglobin. Ten percent is transported as dissolved gas.1 As the tissues extract an increasing amount of oxygen from the blood, the deoxygenated hemoglobin increases its ability to carry carbon dioxide (Haldane effect). Similarly, as an increasing amount of oxygen becomes available in the arterial and venous blood, less carbon dioxide may be carried by the oxidized hemoglobin. This effect has been implicated in the pathogenesis of worsening hypercapnia after oxygen supplementa­tion in patients with baseline hypercapnia.
To achieve optimal gas exchange, local matching of ventilation and perfusion has to occur. The interrelationships between ventilation and blood flow are shown schematically in Fig. 30.1, in which imbalance (B) is typified by bronchospasm, shunt (C) is typified by dense pneumonia or severe acute respiratory distress syndrome (ARDS), and dead space (D) is typified by destruction of the capillaries in emphysema.
Normally, both ventilation and perfusion exhibit a gradient from the top to the bottom of the lung. However, the gradient is more pronounced in blood flow than in ventilation, such that in the upper portions of the lung there are predominantly high V/Q areas and in the lower portions of the lung there are low V/Q areas. The overall V/Q ratio of the normal lung is 0.8.
depends primarily on the hemoglobin concentration
2
2
308
CHAPTER 30 Acute Respiratory Failure 308.e1
https://t.me/medicina_free
Keywords
acute hypoxemic respiratory failure oxygen therapy noninvasive ventilation mechanical ventilation extracorporeal membrane oxygenation
CHAPTER 30 Acute Respiratory Failure 309
=−−
V / O
ABCD
https://t.me/medicina_free
TABLE 30.1 Berlin Definition of Acute
Respiratory Distress Syndrome
Timing Within 1 week of a known clinical insult or
new or worsening respiratory symptoms.
Normal
Fig. 30.1 Schematic representation of various patterns of ventila-
tion (V) and perfusion (Q). A, Normal V/Q ratio in which the PVO
=
40 mm Hg and PCO2 = 46 mm Hg. After equilibration, the
capillary PO2 = 101 mm Hg, PCO2 = 40 mm Hg, and P(A a)O2
=
0 mm Hg. B, V/Q imbalance caused by airway obstruction would decrease the PO mental oxygen. C, A shunt allows mixed venous blood to traverse the capillary without any gas transfer. D, Dead space, the ventilated area of the lung that does not participate in gas exchange. (From Greene KE, Peters JI. Pathophysiology of acute respiratory failure. Clin Chest Med. 1994;15:1–11.)
V / O
Imbalance
. This could be corrected with supple-
2
Shunt Dead space
Chest imaging (radiograph
or computed tomography)
Origin of edema Respiratory failure not fully explained by
2
Oxygenation Mild: PaO
CPAP, Continuous positive airway pressure; FIO2, fraction of inspired oxygen; PaCO2, partial pressure of arterial carbon dioxide; PEEP, positive end-expiratory pressure.
Bilateral opacities not fully explained by
effusions, lobar/lung collapse, or nodules.
cardiac failure or fluid overload.
Need objective assessment (e.g.,
echocardiography) to exclude hydrostatic edema if no risk factor present.
/FIO2 ratio of 200–300 mm Hg with
2
PEEP or CPAP 5 cm H2O
Moderate: PaO
with PEEP or CPAP 5 cm H2O
Severe: PaO
or CPAP
/FIO2 ratio of 100–200 mm Hg
2
/FIO2 < 100 mmg Hg with PEEP
2
5 cm H2O
The overall efficiency of gas exchange can be assessed in terms of maintenance of normal PaO2 and PaCO2. The assessment can be performed by calculating the alveolar-arterial partial pressure oxygen difference (PAO2 – PaO2), which is also known as the A-a gradient. The mean alveolar oxygen tension (PaO2) is calculated by using the alveolar gas equation as follows:
PO FIOPBPHO PaCO R
A2 22 2
()
where PB is the barometric pressure of the atmosphere, which changes with altitude; FIO2 is the fraction of inspired oxygen (approximately 0.21 in room air); PaCO2 is the partial pressure of arterial carbon dioxide; and R is the respiratory quotient. This equation gives an estimation of PaO2, which changes with altitude (PB), with inspired oxygen concentration, and with PaCO2. PaO2 not only changes with changes in PAO2 but also decreases with age in normal individuals. Therefore PAO2-PaO2 increases with age and can be estimated in most adults breathing room air to be approximately 4 mm Hg for each decade of life until the maximum of the seventh decade. This estimation is not valid for patients receiving oxygen supplementation. For these patients, assessment of efficiency of gas exchange can be obtained using the ratio of PaO2 to FIO2 (PaO2/FIO2 ratio normally is >400 mm Hg). Although it is not as accurate as the PAO2-PaO2 difference, it is useful clinically because most patients with ARF receive supplemental oxygen at the time that blood gas analysis is performed. This ratio also forms one of the basic criteria for the diagnosis of ARDS. By consensus, ARDS is defined by PaO2/FIO2 ratio less than or equal to 300 mm Hg when respiratory failure is present and not otherwise explained by cardiac failure or fluid overload (Table 30.1).3 This ratio is most helpful when used serially or when the ratio changes significantly with a therapeutic maneuver.
PATHOPHYSIOLOGY OF ACUTE RESPIRATORY FAILURE
The three most important pathophysiologic mechanisms that cause ARF are hypoventilation, V/Q mismatch, and shunt. Dif­fusion abnormalities, which occur with mild pulmonary edema or early interstitial lung disease, may cause exercise-induced hypoxemia but rarely cause clinically significant hypoxemia. Reduction of inspired PO2 and venous admixture are other potential but less common causes of hypoxemia.
Hypoventilation can be defined as the inadequate movement of fresh alveolar gas necessary for maintaining a normal PaCO2. Pure hypoventilation is a relatively uncommon clinical event. In most cases, hypoventilation occurs along with other causes of hypoxemia. When pure hypoventilation does occur, it is usually caused by depression of the respiratory center by sedative-hypnotic drugs or by neuromuscular diseases that affect the respiratory muscles.
The increase in PaCO hypoventilation invariably affects PaO2 as predicted in the alveolar gas equation, causing a decrease in PaO2. This results in hypoxemia with a normal PAO2-PaO2 gradient. In patients on room air, the PaO2 will fall 5 mm Hg for every 3 mm Hg rise in PaCO2. If the PAO2-PaO2 gradient is abnormally increased, then other mecha­nisms may also be involved in the pathogenesis of hypoxemia. Hypoxemia resulting from pure alveolar hypoventilation usually responds adequately to increasing FIO2.
By far, the most common cause of clinically important hypoxemia is V/Q mismatching, which is present as a continuum from pure shunt (Q, without V) to pure dead space ventilation (V without Q) and unlimited patterns of V/Q mismatching in between. In young normal individuals, V/Q ratios range from
0.6 to 3.0 and usually center around 1.0.4 Low V/Q lung units
that accompanies pure alveolar
2
310 PART IV Noncoronary Diseases: Diagnosis and Management
() ()
PP
22
Ventilation-Perfusion Ratio
ACUTE RESPIRATORY FAILURE
P
and P
(mm Hg)
O Content (mL/100 mL)
https://t.me/medicina_free
can result from compromised ventilation, such as obstructed airways or from partial alveolar filling with pneumonia or pulmonary edema. High V/Q lung units most often occur with obstruction of blood flow owing to pulmonary vascular disease or from a lack of capillaries owing to lung parenchymal destruc­tion, such as that seen in emphysema.
V/Q mismatching causes hypoxemia and hypercapnia. However, in most cases, an increase in minute ventilation stimulated by hypercapnia results in normalization of PaCO2 with persistent hypoxemia. This is possible because the CO2 dissociation curve is linear, allowing well-ventilated areas to compensate. The O2 dissociation curve is sigmoid shaped; therefore, the increase in minute ventilation, despite producing higher end-capillary PO2, results in very modest changes in oxygen saturation, which in most cases is inadequate to reverse the hypoxemia (Fig. 30.2). Hypoxemia due to V/Q mismatching is usually correctable by increasing the FIO2. Local hypoxia in low V/Q areas triggers reflex hypoxic pulmonary vasoconstriction in an attempt to correct the V/Q imbalance. This reflex vasoconstriction can be abolished by a number of vasodilators, including nitroprusside, nitroglycerin, calcium channel blockers, and inhalational anesthet­ics. When compensatory mechanisms fail in a patient with severe lung disease, the body may set a new steady-state PaCO2 and pH as an adaptive response to conserve the work of breathing.
Right-to-left shunt occurs when there is no ventilation into a lung unit while perfusion is preserved. It is one of the extreme ends in the spectrum of V/Q mismatches. In a normal lung, the amount of shunt present is less than 5%. Shunt in the lung results from atelectasis, severe pulmonary edema, and air space consolidation, such as pneumonia. In addition, right-to-left shunt can also occur as a consequence of arteriovenous malformation and intracardiac shunts from a patent foramen ovale, patent ductus arteriosus, or ventricular septal defect. Shunts cause significant hypoxemia owing to the mixture of oxygenated blood with shunted, poorly oxygenated venous blood. Hypercapnia is
140
120
100
80
2
CO
60
40
2
O
20
Fig. 30.2 Variations in PO2, PCO2, and O2 content in a gas
exchange lung unit as its ventilation-perfusion ratio is progressively increased. This lung is assumed to be breathing air, and the mixed venous blood PO Hg, respectively. (From West JB. Ventilation-perfusion relation­ships. Am Rev Respir Dis. 1977;116:919–943.)
.010.005 0.1 1.0
2
21
2
Content
O
2
PO
2
PCO
2
10
and PCO2 are 40 mm Hg and 45 mm
20
19
18
17
16
15
100
usually not present until the shunt is greater than 50%. In contrast to other mechanisms of respiratory failure, hypoxemia owing to shunting is not responsive to increases in FIO2. This feature of shunt can be conveniently used to separate it from other causes of hypoxemia. Calculation of shunt (Qs/Qt) is easily done by administering 100% oxygen for 15 minutes and then analyzing arterial blood gases. Percent shunt can be estimated using a nomogram or by using the following formula:
Cc Ca
OO

Qs Qt
22
=
Cc Cv
OO
22
100
×
In this equation, C denotes content, and the lowercase letters c, a, and v denote end-capillary, arterial, and venous blood, respectively. A simplified shunt equation assumes that the Cvo2 is normal and that the shunt is less than 25%. This simplified shunt equation states that

Qs Qt
=
aAO O
20
When the FIO2 used is less than 1.0, the resulting calculation is called venous admixture instead of shunt. This reflects the contribution of severe V/Q mismatching, including very low V/Q ratios that approach zero, which may act like shunts when alveoli are not ventilated with 100% oxygen. The hypoxemia of shunts is remarkably resistant to correction by increasing the FIO2. Patients with significant shunts may have the same arterial oxygen saturation when maintained on a relatively toxic FIO2 (near
1.0) or when titrated down to relatively safe FIO2 (0.6 to 0.7).
CLINICAL ASSESSMENT
Patients with ARF commonly have dyspnea. For those with underlying lung disease, dyspnea may be present chronically. Therefore, mild changes in the degree of dyspnea may or may not be perceived. In the presence of significant hypoxemia and acidosis, patients may have symptoms of central nervous system depression ranging from irritability to coma. Patients may also have evidence of the effects of hypoxemia or acidosis on the cardiovascular system, such as arrhythmias, angina, or myocardial infarction. Depending on the underlying disease, other symptoms may also be present. Although they may be important and helpful in evaluating the underlying process causing the respiratory failure, they are not that helpful in evaluating the degree of respiratory dysfunction. For example, the additional symptoms of cough, sputum production, and fever may suggest pneumonia, whereas pleuritic chest pain with certain characteristics may suggest pneumothorax or pulmonary embolism as the cause of the respiratory distress.
Initial physical examination of patients with ARF should focus on overall appearance, vital signs, and the ABCs (airway, breathing, and circulation). In general, patients with ARF have tachypnea, tachycardia, and variable mental status. The degree of alteration of mental status may reflect the severity of the respiratory failure. Confusion or disorientation in the presence of dyspnea and tachypnea may reflect profound hypoxemia or hypercapnia with its attendant respiratory acidosis. Pulsus paradoxus, a decrease in arterial systolic pressure of greater than 10 mm Hg with
CHAPTER 30 Acute Respiratory Failure 311
https://t.me/medicina_free
TABLE 30.2 Radiographic Approach to Acute Respiratory Failure
Radiograph Clinical Characteristics Responses to Oxygen
“White” Chest Radiograph
Pneumonia Fever, leukocytosis, sputum production + to + + + Acute respiratory distress syndrome Predisposing risk factors, bilateral infiltrates on imaging + to + + Cardiogenic edema Paroxysmal nocturnal dyspnea, orthopnea, edema + + + to + + + + Interstitial lung disease Prior chest radiographic abnormalities + + + to + + + +
“Black” Chest Radiograph
Chronic obstructive pulmonary disease/asthma Reduced flow on bedside spirometry + + to + + + + Pulmonary emboli Acute dyspnea, pleuritic pain + + + to + + + + Right-to-left shunt History and physical examination consistent with pulmonary
hypertension
Microatelectasis Postoperative or rib fracture, bronchial breath sounds + + to + + +
a
Range from +, which is shuntlike (Po2 increases 1 mm Hg for 1% rise in FIO2), to + + + +, which is V/Q imbalance (Po2 increases 5 mm Hg for
1% rise in FIO2).
+
a
inspiration, also suggests severe airway obstruction associated with significant negative intrathoracic pressures. Patients with severe respiratory distress are usually unable to speak in full sentences. Likewise, the presence or absence of adventitious breath sounds may assist the clinician in evaluating the degree and acuity of the respiratory distress. Crackles suggest alveolar flooding or early bronchopneumonia, whereas rhonchi often herald an increase in mucus production or an inability to clear secretions. Wheezing suggests airway obstruction, whereas wheezes located over the neck suggest upper airway stridor that may be associated with respiratory collapse. Decrease in breath sounds may be seen in patients with chronic obstructive pulmonary disease (COPD) or those with severe airway obstruction. The absence of wheezing and breath sounds in a patient with underlying obstructive lung disease and respiratory distress may suggest impending respira­tory collapse as a result of very limited air movement. Absence of breath sounds may also be associated with pneumothorax. Subcutaneous emphysema usually indicates pneumomediastinum with or without accompanying pneumothorax.
Despite advances in noninvasive technologies in oxygenation assessment, arterial blood gas analysis remains the best and most accurate test in the initial assessment of patients with ARF. Pulse oximetry is acceptable as a method for following oxygenation once it has been calibrated to true blood gas co-oximetry satura­tion and the arterial PaO
is known. Pulse oximetry (SpO2) carries
2
plus or minus 4% error in measuring oxygen saturation. In patients with carbon monoxide poisoning, SpO2 does not reflect true PaO2, and profound hypoxemia may be missed. With methemoglobinemia, the SpO2 may falsely read the oxygen saturation at around 85%, irrespective of the true saturation. Furthermore, pulse oximetry does not give information on PaCO2 and pH, which may be crucial in the differential diagnosis and management of the patient with ARF. The presence of hypercapnia is a marker of the severity of disease. Hypercapnia is more likely to complicate hypoxemic failure when the disease is superimposed on significant underlying lung or neuromuscular disease.
The presence of hypoxemia, hypercapnia, and respiratory acidosis can be used to define ARF; however, it is difficult to set specific levels of PaO2 or PaCO2 because patients with underlying
lung disease may have markedly abnormal baselines. Given these qualifications, patients with ARF generally have a PaO2 less than 55 mm Hg or a PaCO2 more than 50 mm Hg. The pH is very helpful in assessing the acuity of the hypoventilation. In cases of subacute or chronic hypoventilation, the patient usually has an elevated serum bicarbonate level and a mild depression of the pH. In acute respiratory acidosis without renal compensation, the pH drops by 0.08 for each 10 mm Hg rise in PaCO2.
Compensatory bicarbonate retention or wasting by the kidneys to buffer the pH changes usually takes 2 to 3 days to occur. After renal compensation, a change of 10 mm Hg of PaCO2 will produce a 0.03 change in pH in the opposite direction.
The chest radiograph is extremely useful in sorting out the differential diagnosis of ARF during the initial presentation. The causes of hypoxemia can be classified based on radiographic appearance. Table 30.2 shows examples of diseases associated with “white” chest radiographs showing diffuse or patchy infiltrates and diseases associated with “black” chest radiographs showing normal or clear lung fields.
Differential Diagnosis
The clinical classification of ARF based on chest radiographic appearance provides a convenient algorithm in evaluating hypoxemic patients. Posteroanterior and lateral radiographs or computed tomography (CT) of the chest provide better quality than portable films and can help visualize the retrocardiac space. Patients having a “white” chest radiograph usually have pneu­monia, ARDS, cardiogenic pulmonary edema, or progressive interstitial lung disease. Patients having a “black” chest radiograph usually have obstructive lung disease, pulmonary emboli, a right-to-left shunt, or microatelectasis. Most patients with hypoxemic respiratory failure have radiographic infiltrates.
The presence of additional compatible history and physical examination findings often allows the clinician to narrow the differential diagnosis. With fever, cough, sputum production, and lobar or patchy infiltrate, pneumonia is a likely possibility. Pneumonia often presents in an atypical fashion in patients older than 65 years old. fever or specific respiratory complaints; confusion or mild
5
Up to 50% of older patients do not have a